z-logo
open-access-imgOpen Access
Identification of drug side effects with a path-based method
Author(s) -
Meng Jiang,
Bo Zhou,
Lei Chen
Publication year - 2022
Publication title -
mathematical biosciences and engineering
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.451
H-Index - 45
eISSN - 1551-0018
pISSN - 1547-1063
DOI - 10.3934/mbe.2022269
Subject(s) - side effect (computer science) , drug , computer science , identification (biology) , path (computing) , jackknife resampling , task (project management) , side chain , side impact , medicine , mathematics , pharmacology , statistics , chemistry , engineering , biology , botany , systems engineering , estimator , programming language , organic chemistry , structural engineering , polymer
The study of drug side effects is a significant task in drug discovery. Candidate drugs with unaccepted side effects must be eliminated to prevent risks for both patients and pharmaceutical companies. Thus, all side effects for any candidate drug should be determined. However, this task, which is carried out through traditional experiments, is time-consuming and expensive. Building computational methods has been increasingly used for the identification of drug side effects. In the present study, a new path-based method was proposed to determine drug side effects. A heterogeneous network was built to perform such method, which defined drugs and side effects as nodes. For any drug and side effect, the proposed path-based method determined all paths with limited length that connects them and further evaluated the association between them based on these paths. The strong association indicates that the drug has a side effect with a high probability. By using two types of jackknife test, the method yielded good performance and was superior to some other network-based methods. Furthermore, the effects of one parameter in the method and heterogeneous network was analyzed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here